MedPath

MINT-BETAHISTINE

MINT-BETAHISTINE

Approved
DIN Number

02538156

Drug Class

Human

Market Date

Oct 31, 2023

Company
HC

mint pharmaceuticals inc

Product Information

Detailed information about this Health Canada approved drug product, including dosage form, route of administration, and regulatory classification.

Product Details

Health Canada regulatory and product classification information

Regulatory Identifiers
DIN Number02538156
AIG Number0103555004
Classification & Schedule
C
Drug Class
Human
S
Schedule
Prescription
A
ATC Code
N07CA01 BETAHISTINE
Product Specifications
Dosage FormTablet
Route of AdministrationOral
AHFS Classification28:92.00
Health Canada Classification

ACTIVE INGREDIENTS (1)

BETAHISTINE HYDROCHLORIDEActive
Strength: 24 MG
Monograph: BETAHISTINE HYDROCHLORIDE

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.